These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7691242
1. Compound heterozygosity for hemoglobin C and Korle-Bu: moderate microcytic hemolytic anemia and acceleration of crystal formation [corrected]. Nagel RL, Lin MJ, Witkowska HE, Fabry ME, Bestak M, Hirsch RE. Blood; 1993 Sep 15; 82(6):1907-12. PubMed ID: 7691242 [Abstract] [Full Text] [Related]
2. Acceleration of hemoglobin C crystallization by hemoglobin S. Lin MJ, Nagel RL, Hirsch RE. Blood; 1989 Oct 15; 74(5):1823-5. PubMed ID: 2790206 [Abstract] [Full Text] [Related]
3. HbC compound heterozygotes [HbC/Hb Riyadh and HbC/Hb N-Baltimore] with opposing effects upon HbC crystallization. Hirsch RE, Witkowska HE, Shafer F, Lin MJ, Balazs TC, Bookchin RM, Nagel RL. Br J Haematol; 1997 May 15; 97(2):259-65. PubMed ID: 9163585 [Abstract] [Full Text] [Related]
4. Compound heterozygosity for hemoglobin C and hemoglobin Korle-Bu. Kossover CL, Eckman JR, Young AN. Lab Hematol; 2008 May 15; 14(3):30-4. PubMed ID: 18812284 [Abstract] [Full Text] [Related]
5. Molecular interactions between Hb alpha-G Philadelphia, HbC, and HbS: phenotypic implications for SC alpha-G Philadelphia disease. Lawrence C, Hirsch RE, Fataliev NA, Patel S, Fabry ME, Nagel RL. Blood; 1997 Oct 01; 90(7):2819-25. PubMed ID: 9326250 [Abstract] [Full Text] [Related]
6. Differential pathways in oxy and deoxy HbC aggregation/crystallization. Hirsch RE, Samuel RE, Fataliev NA, Pollack MJ, Galkin O, Vekilov PG, Nagel RL. Proteins; 2001 Jan 01; 42(1):99-107. PubMed ID: 11093264 [Abstract] [Full Text] [Related]
7. [Clinical and hematological profile of Lepore Hemoglobin in Ivory Coast]. Sangare A, Sanogo I, Meite M, Segbena A, Toure AH, Elenga JP, Siransy L, Allangba O. Med Trop (Mars); 1994 Jan 01; 54(1):43-6. PubMed ID: 8196525 [Abstract] [Full Text] [Related]
8. Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A). Boucher MO, Chui DH, Woda BA, Newburger PE. Hemoglobin; 2016 Jun 01; 40(3):208-9. PubMed ID: 27117572 [Abstract] [Full Text] [Related]
9. The inhibition of hemoglobin C crystallization by hemoglobin F. Hirsch RE, Lin MJ, Nagel RL. J Biol Chem; 1988 Apr 25; 263(12):5936-9. PubMed ID: 2451674 [Abstract] [Full Text] [Related]
10. Compound heterozygosity for Hb Korle-Bu (beta(73); Asp-Asn) and Hb E (beta(26); Glu-Lys) with a 3.7-kb deletional alpha-thalassemia in Thai patients. Changtrakun Y, Fucharoen S, Ayukarn K, Siriratmanawong N, Fucharoen G, Sanchaisuriya K. Ann Hematol; 2002 Jul 25; 81(7):389-93. PubMed ID: 12185510 [Abstract] [Full Text] [Related]
11. Immunochemical properties of abnormal hemoglobins C-Harlem (beta 6 Glu replaced by Val, beta 73 Asp replaced by Asn), S (beta 6 Glu replaced by Val), Korle Bu (beta 73 Asp replaced by Asn), Vancouver (beta 73 Asp replaced by Tyr), and Mobile (beta 73 Asp replaced by Val). Garver FA, Baker MM, Grenett HE. Biochim Biophys Acta; 1980 Jul 24; 624(1):286-92. PubMed ID: 7407239 [Abstract] [Full Text] [Related]
13. Complex interaction of Hb E [beta26(B8)Glu-->Lys], Hb Korle-Bu [beta73(E17)Asp-->Asn] and a deletional alpha-thalassemia-1 in pregnancy. Siriratmanawong N, Chansri W, Singsanan S, Fucharoen G, Fucharoen S. Hemoglobin; 2009 Sep 24; 33(6):507-14. PubMed ID: 19958198 [Abstract] [Full Text] [Related]
14. Phase separation and crystallization of hemoglobin C in transgenic mouse and human erythrocytes. Canterino JE, Galkin O, Vekilov PG, Hirsch RE. Biophys J; 2008 Oct 24; 95(8):4025-33. PubMed ID: 18621841 [Abstract] [Full Text] [Related]
15. The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Lawrence C, Fabry ME, Nagel RL. Blood; 1991 Oct 15; 78(8):2104-12. PubMed ID: 1912587 [Abstract] [Full Text] [Related]
16. HbS-oman heterozygote: a new dominant sickle syndrome. Nagel RL, Daar S, Romero JR, Suzuka SM, Gravell D, Bouhassira E, Schwartz RS, Fabry ME, Krishnamoorthy R. Blood; 1998 Dec 01; 92(11):4375-82. PubMed ID: 9834244 [Abstract] [Full Text] [Related]
17. [Hemoglobin C (alpha 2 beta 2 6Glu-->lys). Study of 19 heterozygote AC carriers and of 5 cases of double hemoglobinopathy SC]. De Caluwé JP, Alexander M, Bondue H. Acta Clin Belg; 1993 Dec 01; 48(5):297-306. PubMed ID: 8291338 [Abstract] [Full Text] [Related]
18. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease. Cook CM, Smeltzer MP, Mortier NA, Kirk SE, Despotovic JM, Ware RE, Hankins JS. Hemoglobin; 2013 Dec 01; 37(1):16-25. PubMed ID: 23297836 [Abstract] [Full Text] [Related]
19. HPLC-ESI-MS/MS analysis of hemoglobin peptides in tryptic digests of dried-blood spot extracts detects HbS, HbC, HbD, HbE, HbO-Arab, and HbG-Philadelphia mutations. Haynes CA, Guerra SL, Fontana JC, DeJesús VR. Clin Chim Acta; 2013 Sep 23; 424():191-200. PubMed ID: 23796846 [Abstract] [Full Text] [Related]
20. Effect of the beta 73 amino acid on the hydrophobicity, solubility, and the kinetics of polymerization of deoxyhemoglobin S. Adachi K, Kim J, Kinney TR, Asakura T. J Biol Chem; 1987 Aug 05; 262(22):10470-4. PubMed ID: 3611079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]